Enter Symbol
Overview
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Whisper Estimates
Enter Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
GTX INC(NSDQ:GTXI)
GTX Inc is a biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics primarily related to the treatment of serious men''s health conditions. GTx''s drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens.
# Employees:
111
Address:
3 Ndunlap Street 3rd Floor Van Vleet Building,Memphis,TN,USA
Phone:
901-523-9700
Fax:
901-5239772
Website:
www.gtxinc.com
Email:
investor.relations@gtxinc.com
Sector:
Medical
Industry:
MED-BIOMED/GENE
Executive Officers
No Information
Dividend
Ex-Dividend Date:
N/A
Annual Dividend:
N/A
Current Dividend Yield:
N/A
Dividend Paid (3 months):
N/A
Indicated Dividend:
N/A
Earnings
Last Earnings Date:
6/30/2008
Next Earnings Date(Expected):
11/11/2008
Mean EPS (Next Qtr):
($0.42)
Mean EPS (Year):
($1.57)
Mean Estimate(Long Term):
($0.01)
P/E Ratio(Based on EPS estimate):
-0.010
Number of Estimates:
6
Shares Performance
Period
GTXI
Compare to S&P
YTD
28.78 %
49.60 %
4 Weeks
5.00 %
3.47 %
12 Weeks
26.32 %
35.93 %
Shares Information
Analyst Coverage:
Y
Avg Volume:
225429
Shares Outstanding:
36M
Market Cap:
$0.67B
52 Week High:
$19.16
52 Week Low:
$10.79
P/E Ratio:
-0.010
PEG Ratio:
-0.010
Split:
On 1/1/1990 GTXI split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter:
-5.71 %
EPS Growth in Last Year:
-42.31 %
Sales Growth in Last Quarter:
-32.75 %
Sales Growth in Last Quarter:
65.00 %
Financials
Qtr Book Value:
$9.98
Cash Flow/Share:
($0.01)
Change in Payout Ratio:
-0.010
Price/Sales:
60.180
Top Tickers
Home
|
Login
|
Research
|
Earnings
|
Scans
|
Chat Rooms
|
Charts
|
Submit Article
|
Join Blog Network
|
Contributors
|
copryright 2008 all rights reserved
